Results 21 to 30 of about 16,341 (256)

Treatment strategy for acquired pure red cell aplasia: a systematic review and meta-analysis

Blood Advances, 2023
Visual ...
H. Lobbes, J. Lega, Guillaume Le Guenno, M. Ruivard, Sabine Mainbourg   +4 more
semanticscholar   +1 more source

Prevalence of Pure Red Cell Aplasia Following Major ABO-Incompatible Hematopoietic Stem Cell Transplantation

Frontiers in Immunology, 2022
Background Pure red cell aplasia (PRCA) is one of the important complications in major ABO-incompatible allogeneic hematopoietic stem cell transplantation (HSCT).
Panpan Zhu, Yibo Wu, D. Cui, Jimin Shi, Jian Yu, Yanmin Zhao, X. Lai, Li-zhen Liu, Jue Xie, He Huang, Yi Luo   +10 more
semanticscholar   +1 more source

Successful Treatment of Neutropenia Associated With T-Cell Large Granular Lymphocytic Leukemia Using Fludarabine. [PDF]

Case Rep Hematol
T‐cell large granular lymphocytic leukemia (T‐LGLL) is an uncommon lymphoproliferative disorder that typically follows a slow clinical course. Symptoms often remain subtle until cytopenia or infection develops. Severe infection secondary to neutropenia represents the major cause of mortality.
Uemura Y, Togitani K, Kumon Y.
europepmc   +2 more sources

SARS-CoV-2 infection associated with aplastic anemia and pure red cell aplasia

Blood Advances, 2022
Aplastic anemia (AA) is a rare life-threatening disorder characterized by pancytopenia and a hypocellular bone marrow. 1 Pure red cell aplasia (PRCA) is a more limited marrow failure syndrome, with primary reduction in red blood cell production and ...
Nicholas C J Lee, B. Patel, Aaron Etra, T. Bat, I. Ibrahim, M. Vusirikala, Mingyi Chen, F. Rosado, J. Jaso, N. Young, Weina Chen   +10 more
semanticscholar   +1 more source

Treatment for pure red cell aplasia after major ABO‐incompatible allogeneic stem cell transplantation: a multicentre study

British Journal of Haematology, 2021
Pure red cell aplasia (PRCA) following allogeneic haematopoietic stem cell transplantation (aHSCT) with major ABO incompatibility is responsible for transfusion dependent anaemia, impaired quality of life and iron overload.
Thomas Longval, J. Galimard, A. Lepretre, F. Suarez, Denise Amiranoff, M. Cazaux, E. Kaphan, D. Michonneau, N. Dhédin, T. Coman, S. Nguyen Quoc, R. Peffault de Latour, M. Resche-Rigon, F. Sicre de Fontbrune   +13 more
semanticscholar   +1 more source

Successful Treatment of Posttransplant Refractory Pure Red Cell Aplasia Following Parvovirus B19 Infection [PDF]

Case Rep Med
Pure red cell aplasia (PRCA), a rare cause of anemia limited to the erythroid lineage, is characterized by normocytic normochromic anemia, severe reticulocytopenia, and markedly reduced or absent erythroid precursors in the bone marrow. We report a 44‐year‐old male with end‐stage renal disease (ESRD) secondary to autosomal dominant polycystic kidney ...
Ansara Y, Marouf O, Abualhumos K, AbuBaha M, Salameh H, Saadeddin H, Al-Sheikh M.   +6 more
europepmc   +2 more sources

Somatic mutations in acquired pure red cell aplasia.

Seminars in hematology (Print), 2022
Acquired pure red cell aplasia (PRCA) is a syndrome characterized by anemia and a marked reduction of erythroid progenitor cells with various etiologies.
T. Kawakami, H. Nakazawa, F. Ishida
semanticscholar   +1 more source

Case Report: Pulmonary Tuberculosis Accompanied by Pure Red Cell Aplasia and Autoimmune Hemolytic Anemia.

American Journal of Tropical Medicine and Hygiene, 2022
Tuberculosis is one of the most common infections worldwide. It has been associated with some hematologic disorders; however, pure red cell aplasia or autoimmune hemolytic anemia is rarely reported.
H. Shimizu, Hiroshi Yamamoto, N. Hiramoto, H. Nishioka   +3 more
semanticscholar   +1 more source

Foscarnet Therapy for Pure Red Cell Aplasia Related to Human Parvovirus B19 Infection in Kidney Transplant Recipients: A Preliminary Exploration

Infection and Drug Resistance, 2021
Background Parvovirus B19-associated pure red cell aplasia (PVB19-PRCA) is an uncommon but serious complication after kidney transplantation. Currently, intravenous immunoglobulin (IVIG) is preferred as the first-line treatment for PVB19-PRCA, but ...
Yedong Yu, Ruijie Bao, J. Lyu, Jianyong Wu, Jianghua Chen, W. Peng   +5 more
semanticscholar   +1 more source

Roxadustat in the treatment of a hemodialysis patient with anti-erythropoietin antibody-mediated pure red cell aplasia

Clinical Kidney Journal, 2021
The main treatment for renal anemia is subcutaneous injection of recombinant human erythropoietin (rHuEPO) [1]. However, this may be complicated by anti-EPO antibody-mediated pure red cell aplasia (PRCA) [2].
Bojun Xu, Suying Liu, Yan Li, Liangbin Zhao, Xin-Chen Song, Tong Chen   +5 more
semanticscholar   +1 more source